Paper41515935
Modified mRNA-Based Therapeutic Strategies for Myocardial Ischemia-Reperfusion Injury.
Cai T and 1 other. Int J Mol Sci, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Modified mRNA-Based Therapeutic Strategies for Myocardial Ischemia-Reperfusion Injury. Papers, record 41515935. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41515935
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Myocardial Reperfusion Injury | Major topic |
| RNA, Messenger | Major topic |
| Genetic Therapy | Major topic |
| Humans | |
| Animals |
Source PubMed
References129
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35317048 | Follistatin-like 1 promotes proliferation of matured human hypoxic iPSC-cardiomyocytes and is secreted by cardiac fibroblasts. | Mol Ther Methods Clin Dev | 2022 | https://conductscience.org/library/papers/35317048 | PubMed |
| 2 | 25628647 | Regulation of IGF -1 signaling by microRNAs. | Front Genet | 2014 | https://conductscience.org/library/papers/25628647 | PubMed |
| 3 | 34478633 | Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease. | Cell Metab | 2021 | https://conductscience.org/library/papers/34478633 | PubMed |
| 4 | 33929904 | Assessing the Association of Mitochondrial Function and Inflammasome Activation in Murine Macrophages Exposed to Select Mitotoxic Tri-Organotin Compounds. | Environ Health Perspect | 2021 | https://conductscience.org/library/papers/33929904 | PubMed |
| 5 | 22651554 | Ischemic preconditioning promotes intrinsic vascularization and enhances survival of implanted cells in an in vivo tissue engineering model. | Tissue Eng Part A | 2012 | https://conductscience.org/library/papers/22651554 | PubMed |
| 6 | 24018375 | Driving vascular endothelial cell fate of human multipotent Isl1+ heart progenitors with VEGF modified mRNA. | Cell Res | 2013 | https://conductscience.org/library/papers/24018375 | PubMed |
| 7 | 36744541 | Diversity of cells and signals in the cardiovascular system. | J Physiol | 2023 | https://conductscience.org/library/papers/36744541 | PubMed |
| 8 | 25774921 | Catestatin exerts direct protective effects on rat cardiomyocytes undergoing ischemia/reperfusion by stimulating PI3K-Akt-GSK3β pathway and preserving mitochondrial membrane potential. | PLoS One | 2015 | https://conductscience.org/library/papers/25774921 | PubMed |
| 9 | 39831819 | Extracellular vesicle-mediated VEGF-A mRNA delivery rescues ischaemic injury with low immunogenicity. | Eur Heart J | 2025 | https://conductscience.org/library/papers/39831819 | PubMed |
| 10 | 34129954 | Ultrasound-assisted C3F8-filled PLGA nanobubbles for enhanced FGF21 delivery and improved prophylactic treatment of diabetic cardiomyopathy. | Acta Biomater | 2021 | https://conductscience.org/library/papers/34129954 | PubMed |
| 11 | 24332029 | The interleukin-1 family: back to the future. | Immunity | 2013 | https://conductscience.org/library/papers/24332029 | PubMed |
| 12 | 39836346 | Melatonin inhibits ferroptosis through the ATF3/GPX4 signaling pathway to relieve myocardial ischemia-reperfusion injury in rats. | In Vitro Cell Dev Biol Anim | 2025 | https://conductscience.org/library/papers/39836346 | PubMed |
| 13 | 25588055 | Synthetic chemically modified mrna-based delivery of cytoprotective factor promotes early cardiomyocyte survival post-acute myocardial infarction. | Mol Pharm | 2015 | https://conductscience.org/library/papers/25588055 | PubMed |
| 14 | 40288393 | Co-occurrence patterns and related risk factors of ischaemic heart disease and ischaemic stroke across 203 countries and territories: a spatial correspondence and systematic analysis. | Lancet Glob Health | 2025 | https://conductscience.org/library/papers/40288393 | PubMed |
| 15 | 31391918 | PKM2, function and expression and regulation. | Cell Biosci | 2019 | https://conductscience.org/library/papers/31391918 | PubMed |
| 16 | 37954462 | Stem Cell-Based Therapy and Cell-Free Therapy as an Alternative Approach for Cardiac Regeneration. | Stem Cells Int | 2023 | https://conductscience.org/library/papers/37954462 | PubMed |
| 17 | 37556386 | Mitochondrial pannexin1 controls cardiac sensitivity to ischaemia/reperfusion injury. | Cardiovasc Res | 2023 | https://conductscience.org/library/papers/37556386 | PubMed |
| 18 | 36902165 | Modified mRNA as a Treatment for Myocardial Infarction. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36902165 | PubMed |
| 19 | 35039671 | 2021 FDA approvals: value driven by COVID-19 vaccines. | Nat Rev Drug Discov | 2022 | https://conductscience.org/library/papers/35039671 | PubMed |
| 20 | 30793306 | VEGF-A promotes angiogenesis after acute myocardial infarction through increasing ROS production and enhancing ER stress-mediated autophagy. | J Cell Physiol | 2019 | https://conductscience.org/library/papers/30793306 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42941960 | N1-Methylpseudouridine-Modified mRNA-Transfected Dendritic Cells Enable Efficient Generation of Functional Tumor Antigen-Specific Cytotoxic T Lymphocytes. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42941960 | PubMed |
| 42765443 | mRNA Therapeutics Beyond Infectious Diseases: Expanding Therapeutic Applications and Future Perspectives. | Immun Inflamm Dis | 2026 | https://conductscience.org/library/papers/42765443 | PubMed |
| 42146021 | MiR-200a-3p protects against myocardial ischemia-reperfusion injury via KEAP1-NRF2 signaling. | Front Physiol | 2026 | https://conductscience.org/library/papers/42146021 | PubMed |
| 42074166 | N-p-trans-Coumaroyltyramine Improves Myocardial Ischemia-Reperfusion Injury: From Cellular Protection to Animal Model Validation and the Discovery of the Target Tcap. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074166 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41515935
GET https://conductscience.org/api/papers/v1/41515935/references?page=2